MedPath

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT01905982
Lead Sponsor
Schön Klinik Berchtesgadener Land
Brief Summary

The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea, increase activity and have impact on parasympathetic activities.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
44
Inclusion Criteria
  • inpatient rehabilitation
  • COPD (Gold stage III and IV)
Exclusion Criteria
  • severe exacerbation in the last four weeks
  • acute infections
  • fever
  • neuritides
  • severe osteoporosis
  • skin disease
  • manic depression

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in BORG-ScaleChange from pre (minute 0) in Borg Scale and directly post intervention

Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea)

Secondary Outcome Measures
NameTimeMethod
COPD Assessment Testbaseline and post intervention

health related Quality of life

physical activity48 h post intervention

measured by Senswear

Chronic Respiratory Questionnairebaseline and post intervention

health related quality of life

Change in lung volumechange from pre (minute0) in residual volume to post intervention

measured by a bodyplethysmograph

parasympathetic activitiesbaseline and post intervention

measured via Biofeedback

Trial Locations

Locations (1)

Schön Klinik Berchtesgadener Land

🇩🇪

Schönau, Bayern, Germany

Schön Klinik Berchtesgadener Land
🇩🇪Schönau, Bayern, Germany
Klaus Kenn, Prof.
Contact
0049865293
kkenn@schoen-kliniken.de
Tessa Schneeberger, MSc
Contact
0049865293
tschneeberger@schoen-kliniken.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.